Nexgel, INC 10-Q quarterly reports

NexGel reports Q1 2026 financial results, highlighting a net loss of $0.9 million and significant capital raising activities to support its Celularity biomaterials acquisition.

NexGel, Inc. reported increased revenue and improved net loss for the nine months ended September 30, 2025, but acknowledged substantial doubt about its ability to continue as a going concern and disclosed material weaknesses in internal controls.

NexGel, Inc. reported a significant revenue increase of over 100% for Q2 2025, alongside improved gross profit and reduced net loss, yet faces substantial doubt about its ability to continue as a going concern.

NexGel, Inc. saw a significant increase in revenue for the first quarter of 2025, driven by growth in contract manufacturing and branded products, but continues to operate at a loss.

NexGel, Inc. saw a significant increase in revenue during the third quarter of 2024, primarily driven by its branded consumer products segment, including recent acquisitions.

NexGel, Inc. saw a 23.4% increase in revenue in the second quarter of 2024, primarily driven by growth in its branded consumer products segment.

NexGel, Inc. saw a significant increase in revenue during the first quarter of 2024, primarily due to growth in both contract manufacturing and branded product sales.